Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Endothelial Growth Factor Receptor-2 | 5 | 2013 | 32 | 1.390 |
Why?
|
| Neurons | 10 | 2019 | 1246 | 1.310 |
Why?
|
| Alzheimer Disease | 6 | 2025 | 972 | 1.020 |
Why?
|
| Mitochondria | 4 | 2019 | 516 | 0.840 |
Why?
|
| Oxidative Stress | 5 | 2013 | 990 | 0.770 |
Why?
|
| Cell Survival | 7 | 2012 | 934 | 0.740 |
Why?
|
| Neurodegenerative Diseases | 2 | 2022 | 138 | 0.710 |
Why?
|
| Hippocampus | 4 | 2025 | 591 | 0.540 |
Why?
|
| Okadaic Acid | 3 | 2019 | 14 | 0.520 |
Why?
|
| Signal Transduction | 6 | 2019 | 2111 | 0.500 |
Why?
|
| Caspases | 5 | 2017 | 148 | 0.500 |
Why?
|
| Culture Media, Serum-Free | 3 | 2010 | 44 | 0.430 |
Why?
|
| Cell Death | 4 | 2012 | 277 | 0.410 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2013 | 180 | 0.410 |
Why?
|
| Cadmium | 3 | 2004 | 54 | 0.410 |
Why?
|
| Rats, Transgenic | 5 | 2025 | 31 | 0.410 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2012 | 297 | 0.410 |
Why?
|
| Enzyme Inhibitors | 3 | 2012 | 457 | 0.400 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2004 | 43 | 0.400 |
Why?
|
| Isoenzymes | 2 | 2004 | 169 | 0.380 |
Why?
|
| Prostaglandin D2 | 4 | 2022 | 26 | 0.380 |
Why?
|
| Oligopeptides | 3 | 2019 | 108 | 0.370 |
Why?
|
| Receptors, Muscarinic | 1 | 2010 | 17 | 0.340 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2022 | 95 | 0.320 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2007 | 105 | 0.320 |
Why?
|
| Acetylcysteine | 3 | 2008 | 57 | 0.320 |
Why?
|
| Rats | 7 | 2025 | 3701 | 0.310 |
Why?
|
| Rats, Inbred F344 | 3 | 2025 | 256 | 0.290 |
Why?
|
| Serum | 1 | 2007 | 17 | 0.280 |
Why?
|
| Reactive Oxygen Species | 2 | 2008 | 518 | 0.280 |
Why?
|
| Phosphorylation | 5 | 2019 | 973 | 0.270 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2007 | 21 | 0.270 |
Why?
|
| Animals | 15 | 2025 | 16695 | 0.270 |
Why?
|
| Disease Models, Animal | 5 | 2025 | 1554 | 0.270 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 103 | 0.260 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2007 | 74 | 0.260 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 100 | 0.260 |
Why?
|
| Mice | 8 | 2023 | 6490 | 0.240 |
Why?
|
| bcl-X Protein | 3 | 2013 | 27 | 0.240 |
Why?
|
| Neuroblastoma | 3 | 2012 | 134 | 0.230 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2025 | 44 | 0.220 |
Why?
|
| Chalcones | 1 | 2024 | 15 | 0.210 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2004 | 82 | 0.210 |
Why?
|
| Mice, Transgenic | 2 | 2023 | 658 | 0.210 |
Why?
|
| Apoptosis | 2 | 2010 | 1541 | 0.200 |
Why?
|
| Proteasome Endopeptidase Complex | 5 | 2023 | 115 | 0.200 |
Why?
|
| Models, Biological | 4 | 2008 | 711 | 0.200 |
Why?
|
| Memory Disorders | 2 | 2023 | 77 | 0.200 |
Why?
|
| Up-Regulation | 2 | 2004 | 534 | 0.200 |
Why?
|
| Presenilin-1 | 1 | 2022 | 27 | 0.200 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 2 | 2019 | 17 | 0.200 |
Why?
|
| Oxidation-Reduction | 1 | 2004 | 448 | 0.190 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2002 | 34 | 0.190 |
Why?
|
| Sulfonamides | 1 | 2002 | 88 | 0.180 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2013 | 21 | 0.170 |
Why?
|
| Cells, Cultured | 4 | 2017 | 1617 | 0.170 |
Why?
|
| Cell Line, Tumor | 4 | 2012 | 2598 | 0.160 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2019 | 36 | 0.150 |
Why?
|
| Calpain | 1 | 2019 | 35 | 0.150 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 436 | 0.140 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 1066 | 0.140 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 90 | 0.140 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2017 | 35 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 3 | 2017 | 506 | 0.140 |
Why?
|
| Neuroprotective Agents | 2 | 2013 | 267 | 0.140 |
Why?
|
| Brain | 1 | 2025 | 1452 | 0.130 |
Why?
|
| Calcium | 1 | 2019 | 487 | 0.120 |
Why?
|
| Antineoplastic Agents | 2 | 2015 | 979 | 0.120 |
Why?
|
| Humans | 8 | 2022 | 42163 | 0.110 |
Why?
|
| Male | 6 | 2025 | 22779 | 0.110 |
Why?
|
| bcl-Associated Death Protein | 1 | 2013 | 7 | 0.100 |
Why?
|
| Multienzyme Complexes | 2 | 2004 | 69 | 0.100 |
Why?
|
| Cysteine Endopeptidases | 2 | 2004 | 64 | 0.100 |
Why?
|
| Ubiquitin | 2 | 2004 | 80 | 0.100 |
Why?
|
| Cyclooxygenase 2 | 2 | 2004 | 106 | 0.100 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 128 | 0.100 |
Why?
|
| Female | 5 | 2025 | 24018 | 0.100 |
Why?
|
| Immunoblotting | 1 | 2012 | 181 | 0.100 |
Why?
|
| Sirolimus | 1 | 2012 | 70 | 0.090 |
Why?
|
| Dinoprostone | 2 | 2022 | 69 | 0.090 |
Why?
|
| Vanadates | 1 | 2010 | 8 | 0.090 |
Why?
|
| Pilocarpine | 1 | 2010 | 8 | 0.090 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2010 | 11 | 0.090 |
Why?
|
| Carbachol | 1 | 2010 | 19 | 0.080 |
Why?
|
| Protein Phosphatase 2 | 1 | 2010 | 25 | 0.080 |
Why?
|
| Protein Kinase C | 1 | 2010 | 124 | 0.080 |
Why?
|
| Transfection | 2 | 2007 | 526 | 0.070 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2008 | 89 | 0.070 |
Why?
|
| Neuropilin-1 | 1 | 2007 | 4 | 0.070 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2007 | 8 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2007 | 151 | 0.070 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2007 | 76 | 0.070 |
Why?
|
| Glutathione | 1 | 2007 | 170 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2006 | 62 | 0.060 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2007 | 160 | 0.060 |
Why?
|
| Phospholipase D | 1 | 2006 | 50 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 159 | 0.060 |
Why?
|
| Inflammation | 2 | 2023 | 729 | 0.060 |
Why?
|
| Estrogens | 1 | 2006 | 202 | 0.060 |
Why?
|
| Diazoxide | 1 | 2024 | 5 | 0.050 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2004 | 31 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2004 | 30 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 135 | 0.050 |
Why?
|
| Culture Media | 1 | 2004 | 96 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 136 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 1737 | 0.050 |
Why?
|
| Ubiquitins | 1 | 2023 | 47 | 0.050 |
Why?
|
| Receptors, Prostaglandin | 1 | 2022 | 10 | 0.050 |
Why?
|
| Prostaglandins | 1 | 2022 | 28 | 0.050 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2023 | 64 | 0.050 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2002 | 26 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 70 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2002 | 93 | 0.050 |
Why?
|
| DNA Primers | 1 | 2002 | 295 | 0.050 |
Why?
|
| Proteins | 1 | 2004 | 383 | 0.040 |
Why?
|
| Base Sequence | 1 | 2002 | 997 | 0.040 |
Why?
|
| Oligomycins | 1 | 2019 | 3 | 0.040 |
Why?
|
| Antimycin A | 1 | 2019 | 5 | 0.040 |
Why?
|
| Calcimycin | 1 | 2019 | 11 | 0.040 |
Why?
|
| Rotenone | 1 | 2019 | 17 | 0.040 |
Why?
|
| Mesencephalon | 1 | 2019 | 42 | 0.040 |
Why?
|
| Creatinine | 1 | 2019 | 102 | 0.040 |
Why?
|
| Antioxidants | 1 | 2002 | 439 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2019 | 158 | 0.040 |
Why?
|
| Microglia | 1 | 2019 | 204 | 0.030 |
Why?
|
| Glycosylation | 1 | 2017 | 111 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2017 | 154 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 303 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 1679 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 1804 | 0.030 |
Why?
|
| Phosphothreonine | 1 | 2006 | 5 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2006 | 21 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2006 | 29 | 0.020 |
Why?
|
| Synucleins | 1 | 2004 | 7 | 0.010 |
Why?
|
| Estradiol | 1 | 2006 | 269 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 95 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2004 | 93 | 0.010 |
Why?
|
| Neoplasms | 1 | 2015 | 1341 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 462 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 1076 | 0.010 |
Why?
|
| Binding Sites | 1 | 2004 | 670 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 382 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 692 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2006 | 933 | 0.010 |
Why?
|
| Cell Line | 1 | 2004 | 1416 | 0.010 |
Why?
|